Panagora Asset Management Inc Exelixis, Inc. Transaction History
Panagora Asset Management Inc
- $21.7 Billion
- Q2 2025
A detailed history of Panagora Asset Management Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 402,790 shares of EXEL stock, worth $15.9 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
402,790
Previous 23,481
1615.39%
Holding current value
$15.9 Million
Previous $866,000
1950.12%
% of portfolio
0.08%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding EXEL
# of Institutions
686Shares Held
260MCall Options Held
1.41MPut Options Held
1.55M-
Black Rock Inc. New York, NY33.5MShares$1.32 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.5MShares$1.09 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA16MShares$634 Million3.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.8MShares$625 Million0.99% of portfolio
-
State Street Corp Boston, MA11.4MShares$450 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.7B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...